DDD Partners’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-187,265
Closed -$1.03M 138
2025
Q3
$1.03M Sell
187,265
-19,882
-10% -$152K 0.07% 76
2025
Q2
$1.55M Sell
207,147
-6,677
-3% -$48.5K 0.17% 59
2025
Q1
$1.4M Buy
213,824
+28,357
+15% +$335K 0.17% 51
2024
Q4
$2.44M Sell
185,467
-46,453
-20% -$478K 0.3% 45
2024
Q3
$1.32M Sell
231,920
-15,195
-6% -$101K 0.14% 54
2024
Q2
$1.45M Buy
247,115
+17,348
+8% +$155K 0.17% 55
2024
Q1
$2.08M Buy
229,767
+8,994
+4% +$107K 0.25% 48
2023
Q4
$2.43M Buy
220,773
+8,984
+4% +$100K 0.33% 46
2023
Q3
$2.83M Buy
211,789
+114,887
+119% +$4.18M 0.41% 45
2023
Q2
$5.32M Buy
96,902
+1,259
+1% +$80.2K 0.74% 41
2023
Q1
$6.51M Buy
95,643
+32,728
+52% +$2.54M 1.02% 35
2022
Q4
$3.81M Buy
62,915
+28,646
+84% +$2.66M 0.61% 34
2022
Q3
$3.44M Sell
34,269
-315
-0.9% -$36.7K 0.62% 37
2022
Q2
$3.05M Buy
34,584
+165
+0.5% +$20.2K 0.53% 34
2022
Q1
$5.22M Buy
34,419
+26,325
+325% +$4.9M 0.72% 35
2021
Q4
$2.58M Buy
+8,094
New +$2.85M 0.35% 46

Other funds holding RBOT

DDD Partners's RBOT Position: Q4 2025 in Review

DDD Partners sold out of Vicarious Surgical (RBOT) in Q4 2025, closing a stake of 187,265 shares — an estimated $1.03M sold.

DDD Partners first reported a position in RBOT in Q4 2021 and held it in 16 quarters. The position peaked at $6.51M in Q1 2023. 36 funds tracked by Wall St. Rank hold RBOT as of Q4 2025.

  • DDD Partners reported no remaining Vicarious Surgical position as of Q4 2025 after selling out during the quarter.
  • DDD Partners sold 187,265 Vicarious Surgical shares in Q4 2025, an estimated $1.03M.
  • DDD Partners first reported a position in Vicarious Surgical in Q4 2021 and held it in 16 quarters.
  • DDD Partners's Vicarious Surgical position peaked at $6.51M in Q1 2023.
  • 36 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2025.

Based on DDD Partners's 13F filing for Q4 2025, filed 22 Jan 2026.